April 10, 2006 – PsychoGenics Inc., Tarrytown, NY and Sosei Co. Ltd., Japan, have entered into a drug discovery collaboration combining Sosei’s Drug Reprofiling Platform and PsychoGenics’ proprietary Drug Discovery Systems. This collaboration aims to rapidly discover and bring to market new CNS therapies.
